Detection and Characterization of the Effect of AB-FUBINACA and Its Metabolites in a Rat Model.

ABSTRACT: Synthetic cannabinoids were originally developed by academic and pharmaceutical laboratories with the hope of providing therapeutic relief from the pain of inflammatory and degenerative diseases. However, recreational drug enthusiasts have flushed the market with new strains of these potent drugs that evade detection yet endanger public health and safety. Although many of these drug derivatives were published in the medical literature, others were merely patented without further characterization. AB-FUBINACA is an example of one of the new indazole-carboxamide synthetic cannabinoids introduced in the past year. Even though AB-FUBINACA has become increasingly prominent in forensic drug and toxicology specimens analyses, little is known about the pharmacology of this substance. To study its

SUBMITTER: Hsin-Hung Chen M 

PROVIDER: S-EPMC5063098 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature